These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2536929)

  • 41. Endothelium-dependent vasodilation by melittin: are lipoxygenase products involved?
    Förstermann U; Neufang B
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H14-9. PubMed ID: 3925796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probucol inhibits oxidative modification of low density lipoprotein.
    Parthasarathy S; Young SG; Witztum JL; Pittman RC; Steinberg D
    J Clin Invest; 1986 Feb; 77(2):641-4. PubMed ID: 3944273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
    Quinn MT; Parthasarathy S; Fong LG; Steinberg D
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2995-8. PubMed ID: 3472245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural requirements for oxidation of low-density lipoprotein by thiols.
    Wood JL; Graham A
    FEBS Lett; 1995 Jun; 366(1):75-80. PubMed ID: 7789522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin.
    Cathcart MK; McNally AK; Morel DW; Chisolm GM
    J Immunol; 1989 Mar; 142(6):1963-9. PubMed ID: 2537865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.
    Mehta JL; Chen J; Yu F; Li DY
    Cardiovasc Res; 2004 Nov; 64(2):243-9. PubMed ID: 15485683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress.
    Galle J; Schneider R; Heinloth A; Wanner C; Galle PR; Conzelmann E; Dimmeler S; Heermeier K
    Kidney Int; 1999 Apr; 55(4):1450-61. PubMed ID: 10201010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.
    Ylä-Herttuala S; Luoma J; Viita H; Hiltunen T; Sisto T; Nikkari T
    J Clin Invest; 1995 Jun; 95(6):2692-8. PubMed ID: 7769108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular modification of low-density lipoproteins.
    Jessup W
    Biochem Soc Trans; 1993 May; 21(2):321-5. PubMed ID: 8395424
    [No Abstract]   [Full Text] [Related]  

  • 52. Antioxidant activity of piperlactam S: prevention of copper-induced LDL peroxidation and amelioration of free radical-induced oxidative stress of endothelial cells.
    Tsai JY; Chou CJ; Chen CF; Chiou WF
    Planta Med; 2003 Jan; 69(1):3-8. PubMed ID: 12567271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
    Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
    J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
    Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
    Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
    J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of EC-SOD suppresses endothelial-cell-mediated LDL oxidation.
    Takatsu H; Tasaki H; Kim HN; Ueda S; Tsutsui M; Yamashita K; Toyokawa T; Morimoto Y; Nakashima Y; Adachi T
    Biochem Biophys Res Commun; 2001 Jul; 285(1):84-91. PubMed ID: 11437376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein.
    Dzeletovic S; Babiker A; Lund E; Diczfalusy U
    Chem Phys Lipids; 1995 Nov; 78(2):119-28. PubMed ID: 8565112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human macrophage-mediated oxidation of low-density lipoprotein is delayed and independent of superoxide production.
    Garner B; Dean RT; Jessup W
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):421-8. PubMed ID: 8042984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells.
    Navab M; Hama SY; Van Lenten BJ; Drinkwater DC; Laks H; Fogelman AM
    J Clin Invest; 1993 Mar; 91(3):1225-30. PubMed ID: 8450051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.